异种移植
肺
医学
先天免疫系统
补体系统
免疫系统
免疫学
狒狒
炎症
移植
癌症研究
内科学
作者
Lars Burdorf,Christopher Laird,Donald G. Harris,Margaret Connolly,Zahra Habibabady,Emily Redding,Natalie OʼNeill,Arielle Cimeno,Dawn Parsell,Carol J. Phelps,David Ayares,Agnes M. Azimzadeh,Richard N. Pierson
摘要
Galactosyl transferase knock-out pig lungs fail rapidly in baboons. Based on previously identified lung xenograft injury mechanisms, additional expression of human complement and coagulation pathway regulatory proteins, anti-inflammatory enzymes and self-recognition receptors, and knock-down of the β4Gal xenoantigen were tested in various combinations. Transient life-supporting GalTKO.hCD46 lung function was consistently observed in association with either hEPCR (n = 15), hTBM (n = 4), or hEPCR.hTFPI (n = 11), but the loss of vascular barrier function in the xenograft and systemic inflammation in the recipient typically occurred within 24 h. Co-expression of hEPCR and hTBM (n = 11) and additionally blocking multiple pro-inflammatory innate and adaptive immune mechanisms was more consistently associated with survival >1 day, with one recipient surviving for 31 days. Combining targeted genetic modifications to the lung xenograft with selective innate and adaptive immune suppression enables prolonged initial life-supporting lung function and extends lung xenograft recipient survival, and illustrates residual barriers and candidate treatment strategies that may enable the clinical application of other organ xenografts.
科研通智能强力驱动
Strongly Powered by AbleSci AI